Be A Quitter: Illinois Small Business EX Program Dissemination

Disseminate the EX tobacco cessation program to Illinois small businesses

Study Overview

• Status: Completed
• Conditions: Tobacco Use
• Intervention / Treatment: Behavioral: EX program

Detailed Description

This project is designed to provide small businesses throughout Illinois the opportunity to provide a proven tobacco cessation program to their employees at no or reduced cost to the business. The investigators will examine practices that facilitate dissemination of the program, employee usage, as well as benefits of enrollment for individual's mental health, workplace functioning, and family relationships.

• Study Type: Interventional
• Enrollment (Actual): 28
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Illinois
    • Urbana, Illinois, United States, 61801
      • University of Illinois Extension

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Resident of Illinois
• 18 years of age or older
• Current tobacco user
• Seeking to quit tobacco use and willing to participate in the EX program
• Willing to answer surveys at 5 occasions over the course of a year
• Employed at collaborating business in Illinois

Exclusion Criteria:

• Not employed at collaborating business in Illinois

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: EX program participant; Individual who signs up for digital tobacco cessation program (EX program)	Behavioral: EX program; Quit plan with interactive exercises, educational videos, and tailored text messages and emails; peer support; coach chatting; nicotine replacement therapy (patches, gum, or lozenges). All components are self-selected.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Participant enrollment	Number of individuals that enroll	Through study completion, an average of 1 year
Quit planning	Number of steps completed for quit plan	Through study completion, an average of 1 year
Business enrollment	Number of businesses that enroll	Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
General Quality of Life	1 item quality of life measure from World Health Organization brief quality of life assessment (1-5, higher is better quality of life)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up
General Health	4 items from RAND (Research and Development) Corporation Short Form Health Survey (1-4, higher is better health)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up
Work functioning	1 item of general ability to function at work (1-5 scale, higher is better working functioning)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up
Exercise	1 item of frequency of exercise (1-6, higher is more weekly exercise)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up
Psychological distress	Kessler 6 item psychological distress (1-5, higher is more distress)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up
Alcohol Use	PROMIS (Patient-Reported Outcomes Measurement Information System) 7 item problematic alcohol use (1-5, higher is more problematic alcohol use)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up
Anger	NIH PROMIS 5 item anger measure (1-5, higher is more anger)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up
Couple Relationship Satisfaction	4 item Couple Satisfaction Index (3-21 [summed score], higher is more satisfaction)	Baseline, 3 month, 6 month, 9 month, and 12 month follow-up

Collaborators and Investigators

• Sponsor: University of Illinois at Urbana-Champaign

Study record dates

Study Major Dates

• Study Start (Actual): November 19, 2021
• Primary Completion (Actual): March 31, 2025
• Study Completion (Actual): March 31, 2025

Study Registration Dates

• First Submitted: July 18, 2022
• First Submitted That Met QC Criteria: July 30, 2025
• First Posted (Actual): July 31, 2025

Study Record Updates

• Last Update Posted (Actual): July 31, 2025
• Last Update Submitted That Met QC Criteria: July 30, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: 21520

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No